David J. Triggle

David J. Triggle's AcademicInfluence.com Rankings

David J. Triggle

Medical

#1409

World Rank

#1745

Historical Rank

Pharmacology

#115

World Rank

#147

Historical Rank

medical Degrees

Download Badge

Medical

Why Is David J. Triggle Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David J. Triggle's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

New developments in calcium ion channel antagonists (1983) (462)
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. (1983) (288)
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. (2001) (280)
Ca2+ channel ligands: Structure‐function relationships of the 1,4‐dihydropyridines (1989) (233)
Calcium channel antagonists: clinical uses--past, present and future. (2007) (226)
Calcium channel ligands. (1987) (223)
Drug action and cellular calcium regulation (1987) (215)
1,4-Dihydropyridines as Calcium Channel Ligands and Privileged Structures (2003) (211)
The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations (1988) (210)
L-type calcium channels. (2006) (166)
Cellular action of calcium channel blocking drugs. (1984) (158)
High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. (1982) (156)
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine. (1980) (149)
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine. (1982) (137)
New developments in Ca2+ channel antagonists. (1984) (128)
Pharmacology of agents that affect calcium. Agonists and antagonists. (1980) (124)
The Pharmacology of Physostigmine (1998) (118)
1,4-Dihydropyridine activators and antagonists: structural and functional distinctions. (1989) (113)
1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach. (1988) (109)
gamma-Aminobutyric acid action in guinea-pig ileal myenteric plexus. (1982) (107)
Calcium channel activation in vascular smooth muscle by BAY K 8644. (1984) (105)
Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations. (1991) (102)
Neurotransmitter-receptor interactions (1971) (100)
Calcium, Calcium Translocation, and Specific Calcium Antagonists (1978) (98)
Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644. (1984) (93)
Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain. (1984) (93)
BAY K 8644, a 1,4‐Dihydropyridine Ca2+ Channel Activator: Dissociation of Binding and Functional Effects in Brain Synaptosomes (1984) (93)
Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists. (2000) (93)
QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead. (1992) (92)
Molecular properties of the slow inward calcium channel. Molecular weight determinations by radiation inactivation and covalent affinity labeling. (1983) (92)
The effect of Ca2+ antagonists on mechanical responses and Ca2+ movements in guinea pig ileal longitudinal smooth muscle. (1979) (91)
A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS. (1965) (88)
Calcium, calcium channels, and calcium channel antagonists. (1990) (86)
The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels. (1999) (86)
Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. (1987) (82)
Chemical pharmacology of the synapse (1976) (82)
Drug- and disease-induced regulation of voltage-dependent calcium channels. (1990) (82)
Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations. (1991) (81)
Benzodiazepines and calcium channel function (1986) (74)
ATP‐sensitive K+ channels: Pharmacologic properties, regulation, and therapeutic potential (1993) (74)
The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels. (2003) (73)
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle. (1986) (72)
Calcium antagonists and contractile responses in rat vas deferens and guinea pig ileal smooth muscle. (1979) (72)
Quantitative aspects of drug-receptor interactions. I. Ca2+ and cholinergic receptor activation in smooth muscle: a basic model for drug-receptor interactions. (1973) (71)
Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle. (1984) (71)
Calcium, the Control of Smooth Muscle Function and Bronchial Hyperreactivity (1983) (67)
Binding of [3H]nimodipine to cardiac and smooth muscle membranes. (1982) (67)
Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. (1989) (65)
Calcium‐Channel Drugs: Structure‐Function Relationships and Selectivity of Action (1991) (61)
The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue. (1995) (60)
New ligands for L-type Ca2+ channels. (1990) (59)
Sites of action of phencyclidine. III. Interactions with muscarinic receptors. (1980) (57)
An analysis of the action of cations of the lanthanide series on the mechanical responses of guinea‐pig ileal longitudinal muscle. (1976) (56)
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series. (1988) (56)
Stereoselective and non-stereoselective effects of D 600 (methoxyverapamil) in smooth muscle preparations. (1981) (55)
Effects of Calcium on Excitable Membranes and Neurotransmitter Action (1972) (55)
Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. (1983) (53)
Calcium channel antagonists: cardiovascular selectivity of action. (1995) (52)
STUDIES ON THE CHEMICAL BASIS FOR CHOLINOMIMETIC AND CHOLINOLYTIC ACTIVITY: PART I. THE SYNTHESIS AND CONFIGURATION OF QUATERNARY SALTS IN THE 1,3-DIOXOLANE AND OXAZOLINE SERIES (1962) (49)
Conformational features of calcium channel agonist and antagonist analogs of nifedipine. (1984) (48)
Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levels. (1988) (47)
Structure and physiology of the slow inward calcium channel (1987) (46)
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines. (1994) (45)
Stereoselectivity of drug action (1997) (45)
Effects of smooth muscle calcium antagonists on human basophil histamine release. (1981) (44)
Aortic reactivity of rats with genetic and experimental renal hypertension. (1972) (44)
Calcium Antagonists: Some Chemical‐Pharmacologic Aspects (1983) (44)
The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels. (1998) (42)
Drug targets in the voltage-gated calcium channel family: why some are and some are not. (2003) (42)
Studies on the cholinergic receptor. 6. Synthesis and muscarinic activity of 2-methyl-4-(2-dimethylaminoethyl)-1,3-dioxolane methiodide. (1971) (42)
Actions of Ca2+ antagonists on the guinea-pig ileal myenteric plexus preparation. (1983) (40)
Structural parameters determining cholinergic and anticholinergic activities in a series of 1,3-dioxolanes. (1972) (39)
Binding of A 1,4-dihydropyridine calcium channel activator, (-) S Bay K 8644, to cardiac preparations. (1989) (39)
Current awareness series: Ca2+-channels revisited: problems and promises (1984) (38)
Calcium-channel antagonist binding to isolated vascular smooth muscle membranes. (1982) (38)
Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist. (1996) (37)
Nitrendipine and isoproterenol induce phosphorylation of a 42,000 dalton protein that co-migrates with the affinity labeled calcium channel regulatory subunit. (1984) (37)
Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships. (1999) (36)
1,4‐dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state‐dependent interactions, channel isoforms, and other factors (2003) (36)
Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. (1980) (35)
Subcellular distribution of [3H]nitrendipine binding in smooth muscle. (1984) (35)
Receptor model for the molecular basis of tissue selectivity of 1,4-dihydropyridine calcium channel drugs (1990) (35)
Structural and stereochemical requirements for muscarinic receptor binding. (1979) (35)
The chemist as astronaut: searching for biologically useful space in the chemical universe. (2009) (34)
Sites, mechanisms of action, and differentiation of calcium channel antagonists. (1991) (34)
Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions. (1992) (34)
Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein. (1996) (34)
6-Hydroxydopamine treatment increases beta-adrenoceptors and Ca2+ channels in rat heart. (1986) (33)
CRYSTAL STRUCTURES AND PHARMACOLOGICAL ACTIVITY OF CALCIUM CHANNEL ANTAGONISTS: 2,6‐DIMETHYL‐3,5‐DICARBOMETHOXY‐4‐(UNSUBSTITUTED, 3‐METHYL‐, 4‐METHYL‐ 3‐NITRO‐, 4‐NITRO‐, AND 2,4‐DINITROPHENYL)‐1,4‐DIHYDROPYRIDINE (1982) (33)
Intestinal smooth muscle contraction and the effects of cadmium and A23187. (1975) (33)
Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization. (1994) (31)
Calcium ions and respiratory smooth muscle function. (1985) (31)
Regulation of K+ and Ca2+ channels in experimental cardiac failure. (1991) (31)
Inhibitory actions of a series of Ca2+ channel antagonists against agonist and K+ depolarization induced responses in smooth muscle: an assessment of selectivity of action. (1986) (31)
265. Di-N-substituted 2-halogenoethylamines. Part VI. NN-dialkyl-(or N-alkyl)-2-alkyl(or aryl or arylalkyl) derivatives: synthesis, reactivity, and pharmacology (1963) (31)
Cholinergic ligand interactions (1971) (30)
The Dihydropyridine Receptors (1985) (30)
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes. (1984) (29)
Chiral aspects of drug action at ion channels: a commentary on the stereoselectivity of drug actions at voltage-gated ion channels with particular reference to verapamil actions at the Ca2+ channel. (1991) (29)
Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. (1992) (28)
Patenting the sun: Enclosing the scientific commons and transforming the university—ethical concerns (2004) (28)
A homologous series of permanently charged 1,4-dihydropyridines: novel probes designed to localize drug binding sites on ion channels. (1993) (28)
Effect of diazoxide on aortic reactivity to calcium in spontaneously hypertensive rats. (1973) (25)
New synthetic ligands for L-type voltage-gated calcium channels. (1993) (25)
Drug Discovery and Delivery in the 21st Century (2006) (25)
Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies. (1985) (25)
Angiotensin II receptor antagonism: losartan - sites and mechanisms of action. (1995) (25)
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor (1991) (25)
Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain. (1987) (25)
Mechanisms of contraction induced by partially purified slow reacting substance from human polymorphonuclear leukocytes and leukotriene D in guinea pig ileal smooth muscle. (1981) (24)
Some Aspects of the Role of Lipids in Lipid–Protein Interactions and Cell Membrane Structure and Function (1970) (24)
The Synthesis of Nitrogen-Containing Steroids. I. Diels-Alder Adducts of Steroids and 4-Phenyl-1,2,4-triazoline-3,5-dione1 (1966) (24)
Studies on the noradrenaline alpha-receptor. II. Analysis of the "spare-receptor" hypothesis and estimation of the concentration of alpha-receptors in rabbit aorta. (1967) (24)
Electrophysiologic and biochemical studies on the putative Ca++ channel blocker MDL 12,330A in an endocrine cell. (1987) (24)
Benzodiazepine interactions at neuronal and smooth muscle Ca2+ channels. (1987) (23)
The effects of lanthanum and thulium on the mechanical responses of rat vas deferens. (1976) (23)
Homologous regulation of voltage-dependent calcium channels by 1,4-dihydropyridines. (1989) (23)
Cardiovascular T-type calcium channels: physiological and pharmacological significance. (1997) (22)
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes. (1987) (22)
Calcium Channels in Smooth Muscle (1989) (22)
The action of the ionophores, X-537A and A-23187, on smooth muscle. (1975) (22)
4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studies. (1990) (22)
Chemical aspects of the autonomic nervous system (1976) (22)
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes. (1987) (21)
Mechanism of cholinergic antagonism by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (1970) (21)
Age related changes in Ca2+ channels in spontaneously hypertensive rats. (1991) (21)
The effects of chronic depolarization on L-type 1,4-dihydropyridine-sensitive, voltage-dependent Ca2+ channels in chick neural retina and rat cardiac cells. (1991) (21)
The regulation of receptors, ion channels, and G proteins in congestive heart failure (1990) (20)
Specific and non-specific desensitization of guinea-pig ileal smooth muscle. (1984) (20)
THE REACTION MECHANISMS, SELECTIVITY AND SPECIFICITY OF ACTION OF 2-HALOGENOETHYLAMINES. AN ANALYSIS. (1964) (20)
Commission on the Future of Graduate Education in the Pharmaceutical Sciences: Final Report (1999) (20)
Keep off the Grass (1969) (20)
Dimeric 1,4-dihydropyridines as calcium channel antagonists. (1988) (20)
Further differentiation of cholinergic receptors in leech muscle. (1972) (19)
The actions of diazepam and diphenylhydantoin on fast and slow Ca2+ uptake processes in guinea pig cerebral cortex synaptosomes. (1987) (19)
Relationship between aortic reactivity and blood pressure of renal hypertensive, hyperthyroid, and hypothyroid rats. (1973) (19)
2-Halogenoethylamines and the role of Ca 2+ in adrenergic -receptor activation in the rat vas deferens. (1972) (19)
Medicines in the 21st century Or pills, politics, potions, and profits: Where is public policy? (2003) (19)
The influence of guanyl-5'-yl imidodiphosphate and sodium chloride on the binding of the muscarinic agonist, [3H] cis methyldioxolane. (1980) (19)
BLOCKADE OF ADRENERGIC ALPHA-RECEPTORS BY A CARBONIUM ION. (1962) (19)
Molecular Pharmacology of Voltage‐Gated Calcium Channels (1994) (19)
Calcium and the muscarinic receptor. (1976) (18)
CALCIUM ENTRY AND ACTION AT THE PRESYNAPTIC NERVE TERMINAL (1991) (18)
High affinity binding of phencyclidine (PCP) to crayfish muscle. Displacement by calcium antagonists. (1982) (18)
Benzilycholine mustard and spare receptors in guinea pig ileum (1982) (18)
Concepts and progress in the development and utilization of receptor‐specific fluorescent ligands (1994) (18)
The mechanism of action of ionophore A 23187 on guinea pig intestinal smooth muscle. (1979) (18)
Stereoselectivity of cholinergic activity in a series of 1,3-dioxolanes. (1973) (18)
Quantitative aspects of drug-receptor interactions. II. The role of Ca2+men in desensitization and spasmolytic activity. (1973) (17)
From Gutenberg to Open Science: An Unfulfilled Odyssey (2016) (17)
Studies on the noradrenaline alpha-receptor. I. Techniques of receptor isolation. The distribution and specificity of action of N-(2-bromoethyl)-N-ethyl-1-naphthylmethylamine, a competitive antagonist of noradrenaline. (1967) (16)
Muscarinic receptors in guinea pig ileum. A study by agonist--3H-labelled antagonist competition. (1982) (16)
Effect of an homologous series of aliphatic alcohols on neuronal and smooth muscle voltage-dependent Ca2+ channels. (1992) (16)
Pharmacological receptors: a century of discovery--and more. (2000) (16)
Mechanism of action of benzilylcholine mustard at the muscarinic receptor. (1976) (16)
Diastereoselectivity in the lateral metalation and electrophilic quenching of isoxazolyloxazolines (1992) (15)
Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues. (1991) (15)
Calcium channel antagonists: pharmacological considerations. (1985) (15)
Reactivity of vasa deferentia from spontaneously hypertensive and normotensive Wistar rats. (1980) (15)
Ca2+ channels in chick neural retina cells characterized by 1,4-dihydropyridine antagonists and activators. (1989) (15)
Ca2+ channel ligand sensitive responses to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in vascular smooth muscle. (1986) (15)
Inhibition by D 600 of norepinephrine- and clonidine-induced responses of the aortae from normotensive (WKY) and spontaneously hypertensive rats (SHR). (1982) (15)
The ontogeny of [3H]nitrendipine binding sites and 45Ca2+ uptake processes in brain synaptosomes from spontaneously hypertensive rats. (1986) (14)
Nous sommes tous des bacteries: implications for medicine, pharmacology and public health. (2012) (14)
Chemical Pharmacology of Ca2+ Channel Ligands (1986) (14)
Irreversible antagonism at the adrenergic α-receptor: The role of calcium (1970) (14)
Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs. (1984) (13)
Regulation of ATP-sensitive K+ channels by chronic glyburide and pinacidil administration. (1992) (13)
Effect of thyroid status on β-adrenoceptors and calcium channels in rat cardiac and vascular tissue (1988) (13)
On the other hand: the stereoselectivity of drug action at ion channels. (1994) (13)
Formation of Chromenes and Coumarin Derivatives From Salicylaldehydes and 2-Pentenedioate: Facile Route to 3-Formylcoumarins (1996) (13)
Interaction of phenoxybenzamine with muscarinic receptors and calcium channels. (1984) (13)
Treating desires not diseases: a pill for every ill and an ill for every pill? (2007) (13)
Medicinal chemistry education: what is needed and where is it going? (2005) (13)
Postsynaptic alpha-adrenoceptor characterization and Ca2+ channel antagonist and activator actions in rat tail arteries from normotensive and hypertensive animals. (1986) (13)
Ion channels as pharmacologic receptors: the chirality of drug interactions. (1996) (13)
Homologous and heterologous regulation of voltage-dependent calcium channels. (1990) (12)
Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels. (1999) (12)
Dietary sodium intake: influence on calcium channels and urinary calcium excretion in spontaneously hypertensive rats. (1991) (12)
Ca2+ channel ligand activities in uterine smooth muscle: influence of hormonal status. (1987) (12)
Potential-dependent interactions of nitrendipine and related 1,4-dihydropyridines in functional smooth muscle preparations. (1988) (12)
Responses to noradrenaline of portal vein strips from normotensive and spontaneously hypertensive rats. (1980) (12)
The actions of praziquantel and 1-methyladenine in guinea pig ileal longitudinal muscle (1979) (12)
Functional interactions between organic calcium channel antagonists in smooth muscle. (1985) (12)
Age-dependent changes in voltage-gated calcium channels and ATP-dependent potassium channels in fisher 344 rats (1995) (11)
Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol. (1992) (11)
Vaccines, Viagra, and Vioxx: medicines, markets, and money—when life‐saving meets life‐style (2005) (11)
Studies on the cholinergic receptor. IV. The synthesis and muscarinic activity of 3,7-dimethyl-2,4-dioxo-7-azaspiro[3.4]octane methiodide. (1969) (11)
Continuous Versus Intermittent Nitroglycerin Administration in Experimental Heart Failure: Vascular Relaxation and Radioligand Binding to Adrenoceptors and Ion Channels (1993) (11)
RELEASE INDUCED BY CALCIUM IONOPHORES (1979) (11)
Chemical Pharmacology of Calcium Antagonists (1982) (11)
Voltage-Gated Ion Channels as Drug Targets: TRIGGLE: VOLTAGE-GATED ION CHANNELS AS DRUG TARGETS O-BK (2006) (10)
An Academic Perspective (2007) (10)
On the question of subclassification of α‐adrenoceptors (1973) (10)
Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscle. (1984) (10)
45Ca2+ uptake in rat brain neurons: absence of sensitivity to the Ca2+ channel ligands nitrendipine and Bay K 8644. (1987) (10)
Calcium Antagonists History and Perspective (1990) (10)
Reaction of Iodoarenes and Diethyl 2-Pentenedicarboxylate Under the Heck Reaction Conditions. Formation of 3-Aryl-2-pentenedicarboxylates (1996) (10)
Interaction of azimilide with neurohumoral and channel receptors. (2001) (10)
The responses of carotid vascular strips from spontaneously hypertensive and normotensive rats. (1980) (9)
Inhibition by concanavalin A, dansylcadaverine and bacitracin of muscarinic receptor-mediated desensitization in guinea-pig Ileal smooth muscle. (1983) (9)
Rate-determining Step in the Action of L-Amino-acid Oxidase (1966) (9)
Doctoral Education: Another Tragedy of the Commons? (2002) (9)
Fundamental concepts in drug-receptor interactions : proceedings (1970) (9)
The reactions of 2-halogenoethylamines at the noradrenaline receptor-storage complex. (1965) (9)
Calcium channel antagonists as antioxidants (1994) (9)
The reactivity of iliac vascular strips from spontaneously hypertensive and normotensive rats. (1980) (9)
Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines. (1965) (9)
Dual sites of action of irreversible adrenergic α-receptor antagonists in rabbit aorta (1971) (9)
Requiem for impact factors and high publication charges (2021) (8)
Endogenous Ligands for the Calcium Channel: Myths and Realities (1988) (8)
Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells. (1989) (8)
Interactions of local anesthetics with neuronal 1,4-dihydropyridine binding sites. (1991) (8)
Drug−Membrane Interactions. Analysis, Drug Distribution, Modeling. Methods and Principles in Medicinal Chemistry, Volume 15 By J. K. Seydel and M. Wiese. Wiley-VCH, Weinheim, Germany. 2002. xix + 349 pp. 17.5 × 24.5 cm. ISBN 3 527 3042 7. $128.00. (2003) (8)
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for a 3 receptors (1998) (8)
Studies on the cholinergic receptor. II. Monosubstituted and bicyclic derivatives of cis-2-methyl-4-dimethylaminomethyl-1,3-dioxolane methiodide. (1969) (8)
Receptor Targets in Drug Discovery and Development (2003) (8)
Calcium Antagonists in Atherosclerosis: A Review and Commentary (1988) (8)
Chemical and pharmacological approaches to the definition and quantitation of calcium channels. (1983) (8)
Pharmacology of Cav1 (L-Type) Channels (2004) (8)
Mechanism of tissue-selective drug action in the cardiovascular system. (2005) (8)
Studies on the cholinergic receptor. 3. Parasympatholytic properties of cis- and trans- 4-dimethylaminomethyl-2-phenyl-1, 3-dioxolane methiodide. (1969) (8)
New advances in molecular pharmacology of Ca2+ channels. (1989) (8)
Effects of 17β-estradiol and progesterone on agonist-stimulated inositol phospholipid breakdown in uterine smooth muscle (1987) (8)
Pharmaceutical Sciences in the Next Millennium (1999) (7)
Receptor recruitment and cryptic signals (1982) (7)
Calcium reactivity and antagonism in portal veins from spontaneously hypertensive and normotensive rats. (1984) (7)
Regulation of L-type Calcium Channels in Pituitary GH4C1 Cells by Depolarization* (2001) (7)
Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors. (1991) (7)
Selective fluorescent ligands for pharmacological receptors (1994) (7)
CRYSTAL STRUCTURES OF CALCIUM CHANNEL ANTAGONISTS: 2,6-DIMETHYL-3,5-DICARBOMETHOXY-4-(2-NITRO-, 3-CYANO-, 4-(DIMETHYLAMINO)-, AND 2,3,4,5,6-PENTAFLUOROPHENYL)-1,4-DIHYDROPYRIDINE (1981) (7)
Calcium channels in smooth muscle. Properties and regulation. (1989) (7)
A concise synthesis of (±)-, (+)-, and (–)-6-methyl-6-azabicyclo[3.2.l]octan-3α-ol (1990) (7)
[Calcium channels and calcium antagonists]. (1986) (7)
Crystal, solution, and molecular modeling structural properties and muscarinic antagonist activity of azaprophen. (1991) (7)
The mechanism of interaction of 2-halogenoethylamines at the noradrenaline receptor. (1965) (6)
The action of the ionophore ionomycin in guinea-pig intestinal smooth muscle. (1983) (6)
CHARACTERIZATION OF BINDING OF THE CA2+ CHANNEL ANTAGONIST, [3H] NITRENDIPINE TO GUINEA - PIG (1983) (6)
Calcium‐dependence and antagonism of responses to α1‐ and α2‐adrenoceptor agonists in vascular tissues from hypertensive and normotensive rats (1984) (6)
Kainic acid lesions decrease striatal dopamine receptors and 1,4-dihydropyridine sites (1988) (6)
Ca2+ utilization in guinea pig ileal longitudinal smooth muscle in response to a series of muscarinic agonists (1979) (6)
Counting Ca2+ channels? (1982) (6)
Di-n-substituted 2-halogenoethylamines. Part VII. NN-dialkyl-2-1′- or -2′-naphthyl derivatives, and some miscellaneous related compounds: synthesis, reactivity, and pharmacology (1963) (6)
Alpha1 and alpha2: a selection of the select (1984) (6)
The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca+ channels of smooth muscle, cardiac muscle and neuronal tissues (2004) (6)
QSAR, DIAGNOSTIC STATISTIC AND MOLECULAR MODELING OF 1,4-DIHYDROPYRIDINE CALCIUM CHANNEL ANTAGONISTS: ADIFFICULT ROAD AHEAD (1992) (6)
Chapter 35. Medicinal Chemistry: Through a Glass Darkly (1993) (6)
Drug Development in the 21st Century: Medicines, Man and Receptors (2004) (6)
Is there a Unique Conformation of Cholinergic Ligands responsible for Muscarinic Activity ? (1970) (6)
Tricarbonylchromium complexes of Hantzsch esters possess robust calcium antagonist activity. (1992) (5)
MEMBRANAL Ca++ TRANSLOCATION AND CHOLINERGIC RECEPTOR ACTIVATION (1972) (5)
In vitro and in vivo characterization of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4- dihydropy ridine as a Ca2+ channel antagonist. (1987) (5)
On the reversal by (+) and (-)-propranolol of irreversible α-adrenoceptor blockade in rabbit aorta (1974) (5)
Irreversible modification of the voltage-sensitive calcium channel by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). (1990) (5)
Cellular calcium metabolism: activation and antagonism. (1984) (5)
Effect of thyroid status on \-adrenoceptors and calcium channels in rat cardiac and vascular tissue (2004) (5)
Synthesis and evaluation of esters of N,N-bis(2-chloroethyl)-p-aminophenol and N,N-bis(2-bromoethyl)-p-aminophenol as potential antitumor agents. (1969) (5)
Calcium Antagonists and Ionophores (1985) (5)
Structure-Function Relationships of 1,4-Dihydropyridines: Ligand and Receptor Perspectives (1985) (5)
Recent development in calcium channel antagonists. (1989) (5)
Interactions of analogs of the 1,4-dihydropyridine tiamdipine in cardiac and smooth muscle. (1991) (5)
Calcium Channel Antagonists: Pharmacologic and Radioligand Binding Approaches to Mechanisms of Action (1984) (4)
Ion channels and diseases (1994) (4)
Synthesis and stereoselective reduction of (±)-, (+)- and (-)-6-substituted-6-azabicyclo[3.2.1]octan-3-one (1991) (4)
Synthesis of azetidin-3-ol (1968) (4)
Pharmaceuticals in Society (2010) (4)
Potential folic acid antagonists. 5. Synthesis and dihydrofolate reductase inhibitory activities of 2-amino-4,6-substituted-5-arylazopyrimidines. (1971) (4)
Synthesis of 2-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]octanes and 2α-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-enes as Potential Muscarinic Agonists (1992) (4)
Receptor chemistry towards the third millennium. (2000) (4)
Receptor Targets in Drug Discovery (2006) (4)
Inhibition by methoxyverapamil of the responses of smooth muscle from spontaneously hypertensive and normotensive rats. (1982) (4)
The Regulation of Neuronal Calcium Channels (1993) (4)
The preparation and diazotisation of some o- and p-aminophenyl benzoates and benzamides (1968) (4)
N4-(2-bromoethyl)-N4-ethylsulfanilamide, a monofunctional nitrogen mustard with antitumor action. (1965) (4)
Aryldiazonium salts as antagonists at cholinergic muscarinic receptors. (1974) (3)
Benzilylcholine mustard and spare receptors in guinea pig ileum. (1982) (3)
THE SHAPE OF MEDICINES TO COME: PHARMACEUTICALS IN THE 21ST CENTURY (2004) (3)
Ion channels as targets for drug design (1996) (3)
Subcellular distribution of dihydropyridine isothiocyanate binding in guinea-pig ileal smooth muscle. (1985) (3)
The action of diazoxide analogs on aortic reactivity in normotensive and spontaneously hypertensive rats. (1977) (3)
28 – THE TRANSITION FROM AGONIST TO ANTAGONIST ACTIVITY: SYMMETRY AND OTHER CONSIDERATIONS (2003) (3)
More sites for Ca2+ channel antagonists? (1985) (3)
Demonstration of central nervous system tolerance to ethanol in mice: consequent effects on smooth muscle in vitro. (1983) (3)
Hijacked receptors. (2000) (3)
The Chemistry of Calcium Channel Agonists and Antagonists (1988) (3)
1,4-Benzodioxanes as reversible and irreversible antagonists at adrenergic receptors. (1974) (3)
Desensitization of ionophore A23187 responses by muscarinic receptor stimulation in intestinal smooth muscle. (1981) (3)
Formation of Chromene Analogs of Homophthalates: Investigation of Condensation Products Derived from 2-Hydroxybenzaldehydes and Diethyl 2-Pentenedicarboxylates (1996) (3)
Antihypertensive mechanism of action and binding sites of nitrendipine. (1986) (3)
Irreversible adrenergic -receptor antagonism by (R)-and (S)-N-(2-chloroethyl)-N-methyl-2-phenyl-2-hydroxyethylamine and related agents. (1973) (3)
α‐Adrenoceptors of aortae from genetically hypertensive rats: reaction with 2‐halogenoethylamines (1972) (3)
Potential folic acid antagonists. 6. Potential irreversible folate reductase inhibitors derived from 2,4-diamino-5-arylazopyrimidines. (1971) (3)
Food dyes: behavioural and neurochemical actions (1982) (3)
A comparison of adrenergic α‐receptors by the use of NN‐dimethyl‐2‐bromo‐2‐phenylethylamine (DMPEA) (1971) (3)
A new synthesis and crystal structure of 2-methyl-2-azabicyclo[3.3.1]nonan-7α-ol (1992) (3)
Ca2+ mobilization: new sites and signals (1984) (3)
Adrenergic receptors. (1972) (2)
Effects of Ca2+ channel ligands on [3H]QNB binding at m1 and m3 muscarinic receptors. (1991) (2)
Effects of 17 beta-estradiol and progesterone on agonist-stimulated inositol phospholipid breakdown in uterine smooth muscle. (1987) (2)
Ca2+ Channels and 1,4‐Dihydropyridine Receptors (1987) (2)
When two heads are better than one (1983) (2)
Sodium Channels, Pain and Analgesia Edited by Kevin Howard and Mark D. Baker. Birkhauser Verlag, Basel, Switzerland. 2005. x + 199 pp. 17 × 24 cm. ISBN 10-3-7643-7062-9. 126 euro. (2006) (2)
1,4-Dihydropyridine activators in the tiamdipine series. (1990) (2)
Characterization of ion movements and their relationship to muscarinic receptor binding and excitation-contraction coupling in guinea pig ileal longitudinal smooth muscle. (1989) (2)
The 1,4‐Dihydropyridine Receptor: A Regulatory Component of the Ca2+ Channel (1984) (2)
MULTIPLE LIGAND BINDING SITES AT THE CHOLINERGIC RECEPTOR (1971) (2)
Fundamentals of biochemical pharmacology. Edited by Z. M. Bacq, R. Cupek, R. Paoletti, and J. Renson. Pergamon Press, Ltd., Headington Hill Hall, Oxford OX3 OBW, England, 1971. xiv + 659 pp. 18 × 26 cm. Price $27.00 (1972) (2)
2,4-diamino-6-substituted-5-(4-carbethoxyphenylazo) pyrimidines as irreversible inhibitors of folic acid reductase. (1966) (2)
Influence of high sodium intake on urinary calcium excretion and cardiac calcium channels in spontaneously hypertensive rats. (1991) (2)
Depolarization as a regulatory signal at voltage-gated calcium channels. (1996) (2)
Faculty Opinions recommendation of Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. (2016) (2)
Pharmaceutical Research: For What, for Whom? Science and Social Policies (2007) (2)
Structures of two inactive nifedipine analog calcium channel antagonists: (I) C17H17N3O4 and (II) C19H20N2O6 (1987) (2)
Faculty Opinions recommendation of A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. (2013) (2)
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective αIA receptor antagonists for the treatment of benign prostatic hyperplasia (2001) (2)
Pharmacology of calcium channel antagonists (1996) (2)
Chapter 24. Ligand Gated and Voltage-Gated Ion Channels (1990) (2)
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations (2004) (2)
Synthesis and binding properties of 2H‐1‐benzopyran‐2 one fluorophore‐linked calcium channel antagonist nifedipine (1,4‐dihydropyridine) analogs (1997) (1)
Irreversible antagonism at the adrenergic alpha-receptor: the role of calcium. (1970) (1)
Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines. (1968) (1)
Faculty Opinions recommendation of Species-specific ant brain manipulation by a specialized fungal parasite. (2014) (1)
Medicinal chemistry: Through a glass darkly (1996) (1)
Some 3-alkoxyestra-1,3,5(10)-trien-17-beta-ols. (1969) (1)
The Ethics of the F Word: Faith‐Based Science in a Faith‐Based World (2004) (1)
Faculty Opinions recommendation of Differential methylation of the TRPA1 promoter in pain sensitivity. (2014) (1)
Histamine desensitization in guinea pig ileal longitudinal smooth muscle (1980) (1)
Binding of nitrendipine (BAY e 5009), a calcium entry blocker, to cardiac membranes (1982) (1)
6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites. (1966) (1)
Rho Chi lecture. Pharmaceutical sciences in the next millennium. (1999) (1)
An interview with Professor David Triggle, Ph.D. (2004) (1)
Topics in pharmaceutical sciences. Edited by D. D. Breimer, and R. Speiser. Elsevier Science Publishers, New York, NY 10017. 1985. X + 480 pp. ISBN 0‐444‐80749‐7. $109.25 (1986) (1)
Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines. (1971) (1)
Neuronal L‐Type Voltage‐Gated Calcium Channels (2008) (1)
New things succeed, as former things grow old (1985) (1)
Drug design: Fact or fantasy? Edited by G. Jolles and K. R. H. Wooldrige. Academic Press, Orlando, FL. 32887 1984. 268 + xv pp. 16 × 24 cm. ISBN 0‐12‐388‐180‐3. $30.00 (1985) (1)
Body enhancement products (2005) (1)
Calcium-dependence and antagonism of responses to alpha 1- and alpha 2-adrenoceptor agonists in vascular tissues from hypertensive and normotensive rats. (1984) (1)
Age-dependent changes in voltage-gated calcium channels and ATP-dependent potassium channels in Fischer 344 rats. (1995) (1)
Erratum: Continuous versus intermittent nitroglycerin administration in experimental heart failure: Vascular relaxation and radioligand binding to adrenoceptors and ion channels (Journal of Cardiovascular Pharmacology (1993) 22 (600-608)) (1994) (1)
Inhibition by cinnarizine of the responses of smooth muscle from spontaneously hypertensive and normotensive rats. (1983) (1)
Where do calcium antagonists fit in today's antihypertensive care? (1988) (1)
Everybody must get cloned: ideological objections do not hold up. (2002) (1)
Diastereoselectivity in the Lateral Metalation and Electrophilic Quenching of Isoxazolyloxazolines. (1993) (1)
Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivatives. (1978) (1)
Faculty Opinions recommendation of A de novo gain-of-function mutation in SCN11A causes loss of pain perception. (2013) (1)
Calcium ionsandrespiratory smooth muscle function (1985) (1)
Formation of Chromenes and Coumarin Derivatives from Salicylaldehydes and 2‐Pentenedioate: Facile Route to 3‐Formylcoumarins. (1996) (1)
Chemical structure and pharmacological activities of Ca2+ channel antagonists (1984) (1)
Faculty Opinions recommendation of Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. (2014) (1)
Faculty Opinions recommendation of Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. (2007) (0)
Faculty Opinions recommendation of Spiritual and religious beliefs as risk factors for the onset of major depression: an international cohort study. (2013) (0)
Division of Medicinal Chemistry--integrins: past, present and future. (2000) (0)
Receptor chemistry towards the third millennium. (2000) (0)
Faculty Opinions recommendation of Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery. (2013) (0)
Formation of Chromene Analogues of Homophthalates: Investigation of Condensation Products Derived from 2-Hydroxybenzaldehydes and Diethyl 2-Pentenedicarboxylates. (1996) (0)
Faculty Opinions recommendation of AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization. (2015) (0)
Effects of Calcium Channel Antagonists on The Myometrium (2020) (0)
Division of Medicinal Chemistry--small molecule inhibitors of protein-protein interactions. (2000) (0)
Faculty Opinions recommendation of Commensal bacteria make GPCR ligands that mimic human signalling molecules. (2017) (0)
Synthesis and Binding Properties of 2H-1-Benzopyran-2-one Fluorophore- Linked Calcium Channel Antagonist Nifedipine (1,4-Dihydropyridine) Analogues. (1997) (0)
Faculty Opinions recommendation of Estrogen protects against the detrimental effects of repeated stress on glutamatergic transmission and cognition. (2013) (0)
Adenosine Receptors as Targets for Drug Discovery. National (215th) Meeting of American Chemical Society Dallas, TX, March 29 to April, 2, 1998. (1998) (0)
Faculty Opinions recommendation of Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency. (2009) (0)
Editorial (1994) (0)
2-Halogenoethylamines as potential folic acid antagonists. I. Synthesis and biological activity of ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)-propyl]-p-aminobenzoate. (1965) (0)
Adenosine Receptors as Targets for Drug Discovery. National (215th) Meeting of American Chemical Society, Dallas, TX, March 29 to April 2, 1998. (1998) (0)
Abstracts of the presentations at the international symposium: Cardiovascular remodeling, ion channelopathies, arrhythmias, and drug treatment, September 25–27, 2001 (2002) (0)
Calcium utilization in contractions of intestinal smooth muscle of the guinea pig (1975) (0)
The effects of erythrosin B (FD & C Red No. 3) on the guinea-pig ileum myenteric plexuslongitudinal muscle preparation (1983) (0)
Faculty Opinions recommendation of A viral aphrodisiac in the cricket Gryllus texensis. (2014) (0)
Overview of Chemical Diversity (2000) (0)
Norepinephrine. Frontiers of clinical neuroscience, vol. 2. Edited by M. G. Ziegler and C. R. Lake. Williams and Wilkins, 428 East Preston Street, Baltimore, MD 21202. 1984. 521 pp. 18 × 26 cm. $85.00 (1985) (0)
Faculty of 1000 evaluation for Lead diversification at the nanomole scale using liver microsomes and quantitative nuclear magnetic resonance spectroscopy: application to phosphodiesterase 2 inhibitors. (2018) (0)
Cardiac Remodeling, Ion Channelopathy, Arrhythmias and Drug Discovery (The CRIAD). International Symposium (2005) (0)
Faculty Opinions recommendation of Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. (2008) (0)
Editorial (1995) (0)
Faculty Opinions recommendation of Identification of an olfactory signal molecule that activates the central regulator of reproduction in goats. (2014) (0)
Two nucleotide binding sites modulate ( sup 3 H) glyburide binding to rat cortex membranes (1991) (0)
Chapter 27 The tissue specificity of calcium antagonists (1997) (0)
Faculty Opinions recommendation of TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling. (2014) (0)
Noordwijkerhout-Camerino--15th Symposium. Trends in drug research. (2005) (0)
He who pays the piper calls the tune (2002) (0)
Faculty Opinions recommendation of Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers. (2018) (0)
Editorial (1996) (0)
Understanding medications: what the label doesn't tell you: By A. Burger. Pp. 206. American Chemical Society, 1995. ISBN 0 84 12 32105 (1996) (0)
Book Review:Release and Uptake Functions in Adrenergic Nerve Granules. Ulf S. von Euler (1981) (0)
Faculty Opinions recommendation of The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation. (2008) (0)
Faculty Opinions recommendation of Chemical composition of vintage preban absinthe with special reference to thujone, fenchone, pinocamphone, methanol, copper, and antimony concentrations. (2008) (0)
Drug Actions and Regulation at Voltage‐Dependent Neuronal Ca2+ Channels (VDCCs) a (1991) (0)
F1000Prime recommendation of The organization of innovation--the history of an obsession. (2014) (0)
F1000Prime recommendation of Placebos without deception: a randomized controlled trial in irritable bowel syndrome. (2011) (0)
Ion channels in the cardiovascular system: Function and dysfunction. P.M. Spooner, A.M. Brown, W.A. Catterall, G.J. Kaczorowski and H.C. Strauss (eds), Futura Publishing Co., Armonk, NY, 1994, xxi + 580 pages, $85.00 (1995) (0)
Editorial (1995) (0)
Overview: The Search for Biologically Useful Chemical Space (2008) (0)
On the reversal by (plus) and (minus)-propranolol of irreversible alpha-adrenoceptor blockade in rabbit aorta. (1974) (0)
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques (1993) (0)
Cell surface receptors. Edited by P. G. Strange. John Wiley and Sons, Inc., One Wiley Drive, Somerset, NJ 08873.1983.298 pp. 16 × 24 cm. Price $79.95 (1984) (0)
2-Halogenoethylamines and receptor analysis. (1965) (0)
Book Review:Pharmacology of Ionic Channel Function: Activators and Inhibitors M. Endo, Y. Kurachi, M. Mishina (2001) (0)
Calcium in Biological Systems (1986) (0)
Reaction of Iodoarenes and Diethyl 2‐Pentenedicarboxylate under the Heck Reaction Conditions. Formation of 3‐Aryl‐2‐pentenedicarboxylates. (1996) (0)
Chronic ethanol-induced changes in cardiac and neuronal ATP-sensitive potassium channels (1992) (0)
221st ACS. Division of Medicinal Chemistry - natural products: nature's combichem. (2001) (0)
Editorial (1994) (0)
Faculty Opinions recommendation of Neurosensory perception of environmental cues modulates sperm motility critical for fertilization. (2014) (0)
Faculty Opinions recommendation of How to make evolution-proof insecticides for malaria control. (2009) (0)
Pharmacological Aspects of Calcium Channels in Nonvascular Smooth Muscle (1993) (0)
Ion Channels Volume 4 Edited by Toshio Narahashi. Plenum Press, New York and London. 1996. XVII + 457 pp. 17 × 25.5 cm. ISBN 0-306-45224-3. $110.00. (1996) (0)
Faculty Opinions recommendation of Blueprint for antimicrobial hit discovery targeting metabolic networks. (2010) (0)
1,4-Dihydropyridines and the 1,4-Dihydropyridine Receptor (1993) (0)
Introduction – On Ion Channels (2006) (0)
From Ion Channels to Cell-to-Cell Conversations Edited by R. Latorre and J. C. Saez. Plenum Press, New York and London. 1997. 16 × 23.5 cm. xxvii + 504 pp. ISBN 0-306-45605-2. $135.00. (1998) (0)
A Concise Synthesis of (.+‐.)‐, (+)‐, and (‐)‐6‐Methyl‐6‐azabicyclo‐(3. 2.1)octan‐3α‐ol. (1991) (0)
Noordwijkerhout-Camerino - 15th Symposium. Trends on drug research. 8-13 May 2005, Noordwijkerhout, the Netherlands (2005) (0)
5-substituted pyrimidines. II. The synthesis of 2-amino-4-hydroxy-6-methyl-5-(2-hydroxy-3-amino)propylpyrimidines. (1967) (0)
Faculty of 1000 evaluation for The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. (2018) (0)
Some 3-alkoxyestra-1,3,5(10)-trien-17β-ols (1969) (0)
Faculty Opinions recommendation of Publication metrics and success on the academic job market. (2014) (0)
Calcium antagonists and atherosclerosis (1991) (0)
Proceedings of the 3rd buffalo milan symposium on molecular pharmacology buffalo new york usa august 1968 (1970) (0)
F1000Prime recommendation of How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. (2009) (0)
Dimeric 1,4‐Dihydropyridines as Calcium Channel Antagonists. (1989) (0)
Intramolecular participation in ester hydrolysis by the diazonium group (1965) (0)
Faculty Opinions recommendation of Acute and chronic elevation of erythropoietin in the brain improves exercise performance in mice without inducing erythropoiesis. (2012) (0)
Drug amplification of contraction in smooth muscle: mechanism of action of new 1,4 benzodioxan drugs (1973) (0)
Bernard Belleau: Medicinal Chemist. 1925–1989 (1992) (0)
The action of lanthanum and the lanthanides on contraction in the intestinal smooth muscle of the guinea pig (1973) (0)
Receptor Physiology (1971) (0)
Faculty of 1000 evaluation for Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. (2018) (0)
Faculty Opinions recommendation of Rescuing US biomedical research from its systemic flaws. (2014) (0)
Faculty Opinions recommendation of Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. (2013) (0)
A New Synthesis and Crystal Structure of 2‐Methyl‐2‐azabicyclo(3.3.1) nonan‐7α‐ol. (1992) (0)
Angiotensin II receptor antagonism : losartan-sites and mechanisms of action. Commentary (1995) (0)
Calcium channels and calcium antagonists [CALCIUMKANALE UND CALCIUMANTAGONISTEN] (1986) (0)
Faculty Opinions recommendation of Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. (2014) (0)
Faculty Opinions recommendation of Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. (2017) (0)
The Renin – Angiotensin – Aldosterone System and Other Vasoactive Substances 206 (2003) (0)
Comprar Dictionary of Drugs on CD-ROM | David J. Triggle | 9780412787607 | Informa Healthcare (2007) (0)
STEREOSELECTIVITY OF CHOLINERGIC ACTIVITY IN A SERIES OF 1,3-DIOXOLANES (1973) (0)
New studies with EDRF and hemoglobin- Are we approaching the mechanism of cerebral vasospasm? (1985) (0)
108 – COMPARATIVE ACTION OF THE LANTHANIDES AND D-600 ON SMOOTH MUSCLE CONTRACTION (1977) (0)
Faculty Opinions recommendation of Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David J. Triggle?

David J. Triggle is affiliated with the following schools:

University of Idaho

David J. Triggle's Academic­Influence.com Rankings

Why Is David J. Triggle Influential?

David J. Triggle's Published Works

Published Works

What Schools Are Affiliated With David J. Triggle?

David J. Triggle's AcademicInfluence.com Rankings